CD8A and neoplasm: Actually, when the combined treatment was used, contralateral non-ECT-treated tumors were highly infiltrated by CD4+ and CD8+ T lymphocytes, probably responsible for the observed 50 % tumor rejection rate of these untreated contralateral tumors [69].